C vs IRD · P/E 16, rev $85.22B vs rev $11.0M
Citigroup Inc. (C) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
C currently screens at market cap $214.73B and trailing P/E 15.5. IRD currently screens at market cap $35.7M.
Not investment advice. Open the C and IRD stock pages for the full models.
Not investment advice.